Hytest

Hytest

Biotechnology Research

We manufacture monoclonal antibodies and antigens that are mainly used as key components of laboratory tests.

About us

Scientific Excellence for IVD. With over 30 years of experience Hytest offers antibodies and antigens for improved patient outcomes in such areas as cardiac markers, infectious, neuroscience and autoimmune disease reagents.

Sivusto
http://www.hytest.fi
Toimiala
Biotechnology Research
Yrityksen koko
11–50 työntekijää
Päätoimipaikka
Turku
Tyyppi
Privately Held
Perustettu
1994
Erityisosaaminen

Sijainnit

  • Ensisijainen

    Intelligate 6th floor

    Joukahaisenkatu 6

    Turku, 20520, FI

    Get directions

Työntekijät Hytest

Päivitykset

  • Näytä organisaatiosivu: Hytest, kuva

    3 439 seuraajaa

    This holiday season, we’re happy to continue our partnership with Gubbe to bring joy to elderly people ❤️ The loneliness of elderly people is a real problem in Finland, and we want to be a part of the solution. Gubbe offers help and companionship to the elderly, and at the same time offers a meaningful part-time job to a young adult.

    • Kuvalle ei ole vaihtoehtoista tekstikuvausta
  • We are proud to sponsor the EFLM Cardiac Marker Award 🏅 The award recognizes remarkable scientific work in the field of cardiovascular diseases 🫀 Applications are now open to young scientists (under 40) who are the first authors of the paper! 🧑🔬 Eligibility: Papers published or accepted between 1 January 2024 and 19 January 2025 in peer-reviewed journals. 📅 Submission Deadline: 19 January 2025. ✅ Requirements: Applicants must be members of an EFLM Full Member National Society/Association and provide supporting documents, including a bio sketch, proof of age, and signed consent from all authors. 🏅 The winner will receive a certificate and €5,000, presented at the 26th IFCC-EFLM EuroMedLab Congress in Brussels (18–22 May 2025). #EFLMaward #YoungScientist #CardiacMarkers #cardiovasculardisease #Award #submissions

    • Kuvalle ei ole vaihtoehtoista tekstikuvausta
  • Did you miss our webinar last week? Don’t worry, you can still catch the recording 🧑💻 Join us for a deep dive into the world of cardiac troponins with two leading experts in the field of cardiovascular diagnostics: Dr. Allan Jaffe and Dr. Ivan Katrukha. ➡️ Register to watch the recording: https://lnkd.in/dW9g7jYA 📌 Keynote speaker Dr. Jaffe presents "Over Thirty Years of Cardiac Troponin – Where Are We Now?" He discusses the evolution of cardiac troponin assays, highlighting their development, the modern benefits of these assays in patient evaluation, and potential gaps that future research may help fill. 📌 Featured speaker Dr. Katrukha discusses the main biochemical features of cardiac troponins that have an impact on the high-sensitive measurement of these biomarkers in the samples of patients. He also talks about new approaches in the immunodetection of troponins that may lead to more specific detection of myocardial infarction. #IVD #CardiacTroponin #assays #CardiovascularDiagnostics #webinar #immunodetection

    • Kuvalle ei ole vaihtoehtoista tekstikuvausta
  • We’ve been at the forefront of #troponin research for 30 years, and continue with cutting edge research to provide you with the most reliable immunoassays for accurate diagnosis and treatment of cardiac patients 🫀 📌 In the late 1980s, cTnI and later cTnT, were proposed as markers of cardiac cell death. Both proteins are now widely used and established as the guideline recommended markers in order to assist in the diagnosis of acute myocardial infarction (AMI). Find the complete Troponins Booklet here: https://lnkd.in/ezzAZZw4 #cardiacmarkers #AMI #immunoassays #IVD

  • Don’t forget to join us next Wednesday for a deep dive into the world of cardiac troponins with two leading experts in the field of cardiovascular diagnostics: Dr. Allan Jaffe and Dr. Ivan Katrukha. 📅 Wednesday November 27th at 5 PM EET Due to high demand and to make it easier for more participants from different regions to join, we have rescheduled the event. 🔗 Register now: https://lnkd.in/dxRarA8c 📌 Keynote speaker Dr. Jaffe will present "Over Thirty Years of Cardiac Troponin – Where Are We Now?" He will discuss the evolution of cardiac troponin assays, highlighting their development, the modern benefits of these assays in patient evaluation, and potential gaps that future research may help fill. 📌 Featured speaker Dr. Katrukha will discuss the main biochemical features of cardiac troponins that have an impact on the high-sensitive measurement of these biomarkers in the samples of patients. He will also talk about new approaches in the immunodetection of troponins that may lead to more specific detection of myocardial infarction. This is a webinar you don’t want to miss! #IVD #CardiacTroponin #assays #CardiovascularDiagnostics #webinar #immunodetection

    • Kuvalle ei ole vaihtoehtoista tekstikuvausta
  • Greetings from Medica 2024 👋 #teamhytest is in Düsseldorf attending MEDICA - Leading International Trade Fair. It’s been a great experience of innovation, collaboration and cutting-edge healthcare solutions. With the best part being, of course, meeting our valued clients, existing and new. If you’re here as well, come meet us at our booth in Hall 3, D64! #IVD #MEDICA2024 #MedicalInnovation #HealthcareSolutions

    • Kuvalle ei ole vaihtoehtoista tekstikuvausta
  • Join us for a deep dive into the world of cardiac troponins with two leading experts in the field of cardiovascular diagnostics: Dr. Allan Jaffe and Dr. Ivan Katrukha. 📅 Tuesday November 19th at 5 PM EET 🔗 Register now: https://lnkd.in/dxRarA8c 📌 Keynote speaker Dr. Jaffe will present "Over Thirty Years of Cardiac Troponin – Where Are We Now?" He will discuss the evolution of cardiac troponin assays, highlighting their development, the modern benefits of these assays in patient evaluation, and potential gaps that future research may help fill. 📌 Featured speaker Dr. Katrukha will discuss the main biochemical features of cardiac troponins that have an impact on the high-sensitive measurement of these biomarkers in the samples of patients. He will also talk about new approaches in the immunodetection of troponins that may lead to more specific detection of myocardial infarction. This is a webinar you don’t want to miss! #IVD #CardiacTroponin #assays #CardiovascularDiagnostics #webinar #immunodetection

    • Kuvalle ei ole vaihtoehtoista tekstikuvausta
  • 🧪Order your free samples now – offer ends 31st October 🧪 We want to offer our valued customers the possibility to experience the reliability of our tumor markers as part of our 30th anniversary celebration. You can now order free samples from our tumor marker portfolio👇 Learn more and see all the products included in the campaign: https://lnkd.in/ekZguBkM #IVD #tumormarkers #cancer #cancerdiagnosis

Samankaltaisia sivuja

Rahoitus

Hytest 1 Kierros yhteensä

Viimeinen kierros

Sarja tuntematon

Sijoittajat

EQT
Katso lisätietoja crunchbasesta